Endoscopy 2023; 55(07): 611-619
DOI: 10.1055/a-2022-6530
DOI: 10.1055/a-2022-6530
Original article
Intravenous paracetamol for persistent pain after endoscopic mucosal resection discriminates patients at risk of adverse events and those who can be safely discharged
Lobke Desomer‡
‡
1
Department of Gastroenterology and Hepatology, Westmead Hospital, Sydney, New South
Wales, Australia
2
Department of Gastroenterology and Hepatology, AZ Delta Hospital, Roeselare, Belgium
3
Department of Gastroenterology and Hepatology, University Hospital of Ghent, Ghent,
Belgium
,
1
Department of Gastroenterology and Hepatology, Westmead Hospital, Sydney, New South
Wales, Australia
3
Department of Gastroenterology and Hepatology, University Hospital of Ghent, Ghent,
Belgium
4
Westmead Clinical School, University of Sydney, Sydney, New South Wales, Australia
,
Leshni Pillay
1
Department of Gastroenterology and Hepatology, Westmead Hospital, Sydney, New South
Wales, Australia
,
1
Department of Gastroenterology and Hepatology, Westmead Hospital, Sydney, New South
Wales, Australia
,
Mayenaaz Sidhu
1
Department of Gastroenterology and Hepatology, Westmead Hospital, Sydney, New South
Wales, Australia
,
1
Department of Gastroenterology and Hepatology, Westmead Hospital, Sydney, New South
Wales, Australia
,
Michael J. Bourke
1
Department of Gastroenterology and Hepatology, Westmead Hospital, Sydney, New South
Wales, Australia
4
Westmead Clinical School, University of Sydney, Sydney, New South Wales, Australia
› Author Affiliations